|
|
|
|
LEADER |
00000cam a2200000Ia 4500 |
001 |
SCIDIR_on1296533495 |
003 |
OCoLC |
005 |
20231120010632.0 |
006 |
m o d |
007 |
cr |n||||||||| |
008 |
220213s2022 xx o 000 0 eng d |
040 |
|
|
|a YDX
|b eng
|c YDX
|d OPELS
|d EBLCP
|d OCLCO
|d UKMGB
|d UKAHL
|d GZM
|d OCLCQ
|
015 |
|
|
|a GBC1I6312
|2 bnb
|
016 |
7 |
|
|a 020387576
|2 Uk
|
019 |
|
|
|a 1296583333
|
020 |
|
|
|a 9780323899420
|q (electronic bk.)
|
020 |
|
|
|a 0323899420
|q (electronic bk.)
|
020 |
|
|
|z 9780323899413
|
035 |
|
|
|a (OCoLC)1296533495
|z (OCoLC)1296583333
|
050 |
|
4 |
|a RC645.7
|
082 |
0 |
4 |
|a 616.99441
|2 23
|
245 |
0 |
0 |
|a Cellular and molecular aspects of myeloproliferative neoplasms.
|n Part B /
|c Edited by Niccol�o Bartalucci, Lorenzo Galluzzi.
|
264 |
|
1 |
|a [Place of publication not identified] :
|b Academic Press,
|c 2022.
|
300 |
|
|
|a 1 online resource.
|
336 |
|
|
|a text
|2 rdacontent
|
337 |
|
|
|a computer
|2 rdamedia
|
338 |
|
|
|a online resource
|2 rdacarrier
|
490 |
1 |
|
|a International review of cell and molecular biology ;
|v 366
|
505 |
0 |
|
|a Intro -- Cellular and Molecular Aspects of Myeloproliferative Neoplasms -- Part B -- Copyright -- Contents -- Contributors -- Philadelphia-negative myeloproliferative neoplasms: From origins to new perspectives -- Acknowledgments -- Conflict of Interest -- References -- Chapter One: The roles of sex and genetics in the MPN -- 1. Introduction -- 2. Sex as a factor in MPN epidemiology -- 3. Biologic basis of sex differences in somatic mutation burden -- 4. Genetic predisposition to CH and the MPN -- 5. Heritable risk factors for CH and MPN
|
505 |
8 |
|
|a 5.1. Familial MPN and myeloid malignancy predisposition syndromes -- 5.2. GWAS identified risk alleles in the general population -- 6. Inflammation as a risk for CH and MPN -- 7. Mutation burden and clinical risk -- 8. Conclusion -- Funding -- Conflicts of interest -- References -- Chapter Two: Transcriptional configurations of myeloproliferative neoplasms -- 1. Introduction -- 2. Studies on the bulk transcriptome of MPN patients -- 3. From bulk to single cell transcriptomic sequencing of MPN patients -- 4. Analysis of splicing abnormalities with RNA-seq
|
505 |
8 |
|
|a 5. Analysis of fusion genes in MPN and post-MPN AML patients -- 6. Concluding remarks and future directions -- References -- Chapter Three: Targets in MPNs and potential therapeutics -- 1. Introduction -- 2. JAK2 mutations -- 2.1. Behind JAK2V617F: The molecular background -- 2.2. JAK2V617F inhibition strategies -- 2.3. Other JAK inhibitors in MF -- 2.4. Concerns emerging from JAK2 inhibition in myelofibrosis -- 3. TPOR/MPL inhibition strategies -- 4. CALR mutations -- 4.1. CALR inhibition strategies -- 4.2. Potential therapies targeting CALR mutants -- 5. Other targeted therapies
|
505 |
8 |
|
|a 3. Driver mutations and beyond in MPN and leukemic transformation -- 3.1. Driver mutations -- 3.2. Non-driver mutations -- 3.3. Clonal evolution of MPN-BP -- 3.4. Mutations affecting signal transduction and transcription regulators -- 3.5. Mutations in epigenetic regulators -- 3.5.1. Preclinical and clinical studies on combinations targeting epigenetic modifiers -- 3.6. Mutations in RNA splicing factors -- 4. Conclusions -- Acknowledgments -- Disclosures -- References -- Chapter Five: Lessons from mouse models of MPN -- 1. ``Of mice and Me��n
|
650 |
|
0 |
|a Bone marrow
|x Diseases
|x Molecular aspects.
|
650 |
|
0 |
|a Bone marrow
|x Diseases
|x Cytology.
|
650 |
|
6 |
|a Moelle osseuse
|0 (CaQQLa)201-0015076
|x Maladies
|0 (CaQQLa)201-0015076
|x Aspect mol�eculaire.
|0 (CaQQLa)201-0374959
|
650 |
|
6 |
|a Moelle osseuse
|0 (CaQQLa)201-0015076
|x Maladies
|0 (CaQQLa)201-0015076
|x Cytologie.
|0 (CaQQLa)201-0379624
|
700 |
1 |
|
|a Bartalucci, Niccol�o.
|
700 |
1 |
|
|a Galluzzi, Lorenzo.
|
776 |
0 |
8 |
|c Original
|z 0323899412
|z 9780323899413
|w (OCoLC)1285579695
|
830 |
|
0 |
|a International review of cell and molecular biology ;
|v 366.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/bookseries/19376448/366
|z Texto completo
|